Product Program year 2025 Source: CMS Open Payments

Mamba

Device Mamba_Ic

PDI 08714729940241

Open in the dashboard

General payments

$22,560

722 payments

Research payments

$0

0 payments

Through program year 2025, $22,560 in general payments and $0 in research payments were reported against Mamba (Mamba_Ic).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $3,327 93
2024 General $5,144 138
2023 General $8,570 246
2022 General $5,519 245

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $22,560 722 payments
Top recipients General payments · program year 2025
  1. Nancy Rizzuto Nurse Practitioner, Adult Health · Brooklyn, NY $247 7% · 2 payments
  2. Salman Arain Interventional Cardiology · Houston, TX $159 5% · 4 payments
  3. Ankur Sethi Interventional Cardiology · Oak Park, IL $154 5% · 2 payments
  4. Delphine Tang Cardiovascular Disease · Edison, NJ $154 5% · 2 payments
  5. Mitul Kanzaria Interventional Cardiology · Sunnyside, WA $154 5% · 2 payments

The top 5 of 64 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $1,374 43% · 31 practitioners
  2. Cardiovascular Disease Internal Medicine $1,311 41% · 21 practitioners
  3. Nurse Practitioner, Adult Health Nurse Practitioner $247 8% · 1 practitioner
  4. Pulmonary Disease Internal Medicine $147 5% · 1 practitioner
  5. Clinical Cardiac Electrophysiology Internal Medicine $31 <1% · 3 practitioners

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New Jersey $1,329 40% · 15 recipients
  2. Oklahoma $572 17% · 4 recipients
  3. New York $264 8% · 2 recipients
  4. Texas $215 6% · 4 recipients
  5. Washington $179 5% · 2 recipients

The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

722 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record